Otoacoustic Emission Study on Patients Treated by Cis-platinum.
نویسندگان
چکیده
منابع مشابه
Otoacoustic Emission in Tinnitus Patients
The purpose of the study was to determine the effect of tinnitus and total effect of tinnitus and the hearing loss function on the distortion product otoacoustic emission. Tinnitus patients were selected to exhibit normal hearing and such tinnitus patients who exhibited the increasing or notch-like sensorineural hearing loss. It was found that the cochlear hearing activity expressed in terms of...
متن کاملAlteration of composition by cis-platinum
We have developed chromatographic and mathematical protocols that allowed the high resolution of glutathione S-transferase (GST) subunits, and the identification of a previously unresolved GST monomer in rat kidney cytosol; the monomer was identified tentatively as subunit 6. Also, an aberrant form of GST 7-7 dimer appeared to be present in the kidney. This development was utilized to illustrat...
متن کاملEvaluation of Distortion and Transient Evoked Otoacoustic Emission in Tinnitus Patients with Normal Hearing
Introduction: Tinnitus is a perception of sound without external source. The exact etiology of tinnitus is not fully understood, although some researchers believe that the condition usually starts in the cochlea. The aim of this study was to determine the potential contribution of outer hair cell dysfunction to chronic tinnitus, by application of Distortion-Product Evoked Otoacoustic Emission (...
متن کاملContralateral suppression of otoacoustic emission in patients with tinnitus.
INTRODUCTION The medial olivocochlear bundle effect is studied through the suppression of otoacoustic emissions and seems to be influenced by the laterality of the central nervous system, presenting no symmetry between right and left ear. A dysfunction of this bundle may be involved in the generation of tinnitus, although this fact was not confirmed. OBJECTIVES Study the suppression of distor...
متن کاملSynthesis of Cis-Diammine (1,1-cyclobutane dicarboxylate) Platinum(II)
Platinum-based anticancer drugs are chemotherapeutic agents to treat cancer. Carboplatin (cis diammine cyclobutane dicarboxylate platinum (II)) is a second generation drug that has less toxic than cisplatin, allowing for high dosages. In the first stage, 1,3-Cyclobutane dicarboxylic acid, a key intermediate for the preparation of carboplatin, have been synthesized in good yields using diffe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: AUDIOLOGY JAPAN
سال: 1995
ISSN: 1883-7301,0303-8106
DOI: 10.4295/audiology.38.237